Retour
Prix Roivant Sciences Ltd (ROIV)
Graphique du cours de l'action ROIV
ROIV Gagner
Roivant Sciences Ltd
$27.93
0.83%
$0.23
À la fermeture : Mar 23, 16:00:00 GMT-4
$27.9
-0.1%
$-0.03
Post-Marché: Mar 23, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$27.7
Prix d'ouverture
$28.03
Plage de la journée
$27.66 - $28.39
Plage de 52 semaines
$8.73 - $30.33
Volume
4.8M
Volume moyen
6.2M
Rendement en dividend
--
BPA (TTM)
-1.17
Capitalisation boursière
$19.9B
Qu’est-ce que ROIV ?
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.